JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Hormone Replacement Therapy

ObligatoryMust not donate if:
a) Used for malignancy.

b) A recipient of human gonadotrophin of pituitary origin.

c) A recipient of human pituitary growth hormone.
Discretionarya) If treated with gonadotrophins that were exclusively non-pituitary derived, accept.

b) If treated with growth hormone that was exclusively recombinant, accept.

c) If treatment for menopausal symptoms or osteoporosis prevention, accept.
See if RelevantPrion Associated Diseases
Thyroid Disease
Reason for ChangeThe discretionary entry has been re-worded for clarity.

Update Information

This entry was last updated in
TDSG-LD Edition 203, Release 02